Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP823964.RA18N4Rdyc2FkZDZbSyyj8cOoEjoARoTvd1SXWvBajKak130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP823964.RA18N4Rdyc2FkZDZbSyyj8cOoEjoARoTvd1SXWvBajKak130_assertion type Assertion NP823964.RA18N4Rdyc2FkZDZbSyyj8cOoEjoARoTvd1SXWvBajKak130_head.
- NP823964.RA18N4Rdyc2FkZDZbSyyj8cOoEjoARoTvd1SXWvBajKak130_assertion description "[GSTT1 active genotype and GSTO1 Asp140Asp and GSTO2 Asp142Asp genotypes may have a prognostic/pharmacogenomic role in patients with muscle invasive bladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP823964.RA18N4Rdyc2FkZDZbSyyj8cOoEjoARoTvd1SXWvBajKak130_provenance.
- NP823964.RA18N4Rdyc2FkZDZbSyyj8cOoEjoARoTvd1SXWvBajKak130_assertion evidence source_evidence_literature NP823964.RA18N4Rdyc2FkZDZbSyyj8cOoEjoARoTvd1SXWvBajKak130_provenance.
- NP823964.RA18N4Rdyc2FkZDZbSyyj8cOoEjoARoTvd1SXWvBajKak130_assertion SIO_000772 24040330 NP823964.RA18N4Rdyc2FkZDZbSyyj8cOoEjoARoTvd1SXWvBajKak130_provenance.
- NP823964.RA18N4Rdyc2FkZDZbSyyj8cOoEjoARoTvd1SXWvBajKak130_assertion wasDerivedFrom befree-20150227 NP823964.RA18N4Rdyc2FkZDZbSyyj8cOoEjoARoTvd1SXWvBajKak130_provenance.
- NP823964.RA18N4Rdyc2FkZDZbSyyj8cOoEjoARoTvd1SXWvBajKak130_assertion wasGeneratedBy ECO_0000203 NP823964.RA18N4Rdyc2FkZDZbSyyj8cOoEjoARoTvd1SXWvBajKak130_provenance.